# STOCKHOLM 1.0
#=GF ID   LRR_RI_capping
#=GF AC   PF18779.5
#=GF DE   Capping Ribonuclease inhibitor Leucine Rich Repeat
#=GF AU   Paladin L;0000-0003-0011-9397
#=GF AU   Piovesan D;0000-0001-8210-2390
#=GF SE   RepeatsDB
#=GF GA   33.00 20.00;
#=GF TC   33.40 31.70;
#=GF NC   31.80 19.30;
#=GF BM   hmmbuild HMM.ann SEED.ann
#=GF SM   hmmsearch --cpu 4 -Z 75585367 -E 1000 HMM pfamseq
#=GF TP   Repeat
#=GF CL   CL0022
#=GF RN   [1]
#=GF RM   24941155
#=GF RT   Functional evolution of ribonuclease inhibitor: insights from
#=GF RT   birds and reptiles.
#=GF RA   Lomax JE, Bianchetti CM, Chang A, Phillips GN Jr, Fox BG, Raines
#=GF RA   RT;
#=GF RL   J Mol Biol. 2014;426:3041-3056.
#=GF DR   INTERPRO; IPR041302;
#=GF DR   SO; 0001068; polypeptide_repeat;
#=GF CC   Leucine-rich repeats are composed of a beta-alpha unit. This 
#=GF CC   repeat unit is found as capping unit (N- or C- terminal of the
#=GF CC   repeat region) of Ribonuclease Inhibitors [1].
#=GF SQ   7
#=GS G3SPV7_LOXAF/6-35         AC G3SPV7.1
#=GS E9PMJ3_HUMAN/6-35         AC E9PMJ3.1
#=GS A0A1B0GSG5_MOUSE/37-66    AC A0A1B0GSG5.1
#=GS A0A1S3GLB5_DIPOR/4-33     AC A0A1S3GLB5.1
#=GS A0A091FSF6_9AVES/1-30     AC A0A091FSF6.1
#=GS A0A151NXF1_ALLMI/539-568  AC A0A151NXF1.1
#=GS K7G802_PELSI/1-29         AC K7G802.1
G3SPV7_LOXAF/6-35                    MNLDIQCEHLSDTQWKELLPRIQQVEVIRL
E9PMJ3_HUMAN/6-35                    QSLDIQCEELSDARWAELLPLLQQCQVVRL
A0A1B0GSG5_MOUSE/37-66               MSLDIQCEQLSDARWTELLPLIQQYEVVRL
A0A1S3GLB5_DIPOR/4-33                MDLNIQCEQLSDSRWAELLPRIQQCQWVRL
A0A091FSF6_9AVES/1-30                MELDVQCEEMSPSRWAELLSTMKSCKVIRL
A0A151NXF1_ALLMI/539-568             MDIDIECQELSGSRWTELVSSMKDCKAIRL
K7G802_PELSI/1-29                    MDLDIQCEELSASRWTELVLSMNTCKTVR.
#=GC seq_cons                        MsLDIQCEcLSsoRWsELLsphppCcslRL
